Abbott, which has the only FDA-approved mitral valve repair device on the U.S. market, stands to win big after the Centers for Medicare & Medicaid Services proposes coverage for transcatheter mitral valve repair or replacement.
Medicare today proposed to cover surgeries to fix or replace leaky heart valves called transcatheter mitral valve procedures, issuing a draft National Coverage Decision for the procedure.
from MassDevice - FDA and Medical device business news and jobs for the medical device industry http://ift.tt/1sB67Gq
Cap comentari:
Publica un comentari a l'entrada